Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q1 2026 vs. Q4 2025
How the institutions holding Cidara Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 255 | 8 | 0 | −247 |
| Shares | 33.3M | 2.71M | 0 | −30.6M (−100.0%) |
| Value | $7.36B | $598.5M | $0 | −$6.76B (−100.0%) |
8 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Cidara Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (247)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
Showing the largest 100 of 247 by value.
Not filed for Q1 2026 yet (8)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 2,007,193 | $443.4M |
| UBS Oconnor LLC | 315,474 | $69.7M |
| Norges Bank | 200,000 | $44.2M |
| Omni Event Management Ltd | 185,313 | $40.9M |
| CIBC World Markets Corp | 1,297 | $286.5K |
| Global Retirement Partners, LLC | 205 | $45.3K |
| Comerica Bank | 12 | $2.56K |
| CIBC Private Wealth Group, LLC | 7 | $1.55K |